Dyskinesia

Dyskinesia are a category of movement disorders characterized by involuntary muscle movements. They can be medication-induced, chronic, or non-motor in nature. Here is the latest research.

July 12, 2020

Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease

Neurology
Heidemarie ZachRick C Helmich
July 12, 2020

Clinical spectrum and genotype-phenotype correlations in PRRT2 Italian patients

European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
Ganna BalaguraPasquale Striano
July 9, 2020

Novel compound heterozygous DNAAF2 mutations cause primary ciliary dyskinesia in a Han Chinese family

Journal of Assisted Reproduction and Genetics
Minghan SunYongxin Ma
July 9, 2020
Case Report

Language regression, hemichorea and focal subclinical seizures in a 6-year-old girl with GLUT-1 deficiency

Epilepsy & Behavior Reports
Alexandra M WoodAhmad Marashly
July 1, 2020
Open Access

The clinical significance of disorders of the motor function of the esophagus, stomach and duodenum

Terapevticheskiĭ arkhiv
A S Trukhmanov, N Y Ivashkina
July 10, 2020
Open Access

Mechanisms of bradycardia in premature infants: Aerodigestive-cardiac regulatory-rhythm interactions

Physiological Reports
Kathryn A Hasenstab-KenneySudarshan R Jadcherla
July 6, 2020

Esophageal Dysmotility is Common in Patients With Multiple System Atrophy

The Laryngoscope
Rumi UehaTatsuya Yamasoba
July 6, 2020
Review

Dentate Nucleus as Target for Deep Brain Stimulation in Dystono-Dyskinetic Syndromes

Neuro-Chirurgie
Claire L NicholsonGaëtan Poulen
July 9, 2020

Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia

Journal of Clinical Psychopharmacology
Stanley N CaroffE Cabrina Campbell
July 3, 2020

Safinamide Mesilate (Equfina® TABLETS 50 mg): preclinical and clinical pharmacodynamics, efficacy, and safety

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Michinori Koebisu, Takayuki Ishida
July 6, 2020

A case of severe autosomal recessive spinocerebellar ataxia type 18 with a novel nonsense variant in GRID2

European Journal of Medical Genetics
Katalin L M L HetzeltChristiane Zweier
July 8, 2020
Preprint
Open Access

Motor and Activity Psychosis-Risk (MAP-R) Scale: An exploration of scale structure with replication and validation

MedRxiv : the Preprint Server for Health Sciences
Katherine S F DammeV. A. Mittal
July 7, 2020

A focused update on tardive dyskinesia

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
Pierre J Blanchet
July 6, 2020

Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset

Naunyn-Schmiedeberg's Archives of Pharmacology
Adjia HamadjidaPhilippe Huot

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Alpha-Synuclein Structure and Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-Synuclein structure and function.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/dyskinesia/89186229-53f7-4500-bbe1-f06cfe22dfbd